Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2

Journal of Virology

Volumn 82, Issue 15, 2008, Pages 7264-7275

  Netland, Jason ^a   Meyerholz, David K ^b   Moore, Steven ^b   Cassell, Martin ^b   Perlman, Stanley ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAUSE OF DEATH; CELL INFILTRATION; CONTROLLED STUDY; CORONAVIRUS; INFECTION SENSITIVITY; INOCULATION; MOUSE; NERVE CELL NECROSIS; NONHUMAN; OLFACTORY BULB; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY FAILURE; SEVERE ACUTE RESPIRATORY SYNDROME; SPINAL CORD COMPRESSION; TRANSGENIC MOUSE; VIRUS ENCEPHALITIS; VIRUS ENTRY; VIRUS INFECTION; VIRUS INFECTIVITY;

ANIMALS; BRAIN; CELL DEATH; HUMANS; LUNG; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; OLFACTORY BULB; PEPTIDYL-DIPEPTIDASE A; RECEPTORS, VIRUS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

ANIMALIA; MURINAE; MUS; SARS CORONAVIRUS;

EID: 47749125832     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00737-08     Document Type: Article

References (57)

1. Akashi, H., Y. Inaba, Y. Miura, K. Sato, S. Tokuhisa, M. Asagi, and Y. Hayashi. 1981. Propagation of the Kakegawa strain of bovine coronavirus in suckling mice, rats and hamsters. Arch. Virol. 67:367-370.
2. Allan, S. M., and N. J. Rothwell. 2001. Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2:734-744.
3. Aloisi, F. 2001. Immune function of microglia. Glia 36:165-179.
4. Arbour, N., R. Day, J. Newcombe, and P. J. Talbot. 2000. Neuroinvasion by human respiratory coronaviruses. J. Virol. 74:8913-8921.
5. Astic, L., D. Saucier, P. Coulon, F. Lafay, and A. Flamand. 1993. The CVS strain of rabies virus as transneuronal tracer in the olfactory system of mice. Brain Res. 619:146-156.
6. Barnett, E. M., and S. Perlman. 1993. The olfactory nerve and not the trigeminal nerve is the major site of CNS entry for mouse hepatitis virus, strain JHM. Virology 194:185-191.
7. Butler, N., L. Pewe, K. Trandem, and S. Perlman. 2006. Murine encephalitis caused by HCoV-OC43, a human coronavirus with broad species specificity, is partly immune-mediated. Virology 347:410-421.
8. Cameron, M. J., L. Ran, L. Xu, A. Danesh, J. F. Bermejo-Martin, C. M. Cameron, M. P. Muller, W. L. Gold, S. E. Richardson, S. M. Poutanen, B. M. Willey, M. E. DeVries, Y. Fang, C. Seneviratne, S. E. Bosinger, D. Persad, P. Wilkinson, L. D. Greller, R. Somogyi, A. Humar, S. Keshavjee, M. Louie, M. B. Loeb, J. Brunton, A. J. McGeer, and D. J. Kelvin. 2007. Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J. Virol. 81:8692-8706.
9. Campbell, I. L., A. K. Stalder, C. S. Chiang, R. Bellinger, C. J. Heyser, S. Steffensen, E. Masliah, H. C. Powell, L. H. Gold, S. J. Henriksen, and G. R. Siggins. 1997. Transgenic models to assess the pathogenic actions of cytokines in the central nervous system. Mol. Psychiatry 2:125-129.
10. Chan, P. K., J. W. Tang, and D. S. Hui. 2006. SARS: clinical presentation, transmission, pathogenesis and treatment options. Clin. Sci. (Lond.) 110: 193-204.
11. Cheng, S. K., J. S. Tsang, K. H. Ku, C. W. Wong, and Y. K. Ng. 2004. Psychiatric complications in patients with severe acute respiratory syndrome (SARS) during the acute treatment phase: a series of 10 cases. Br. J. Psychiatry 184:359-360.
12. Coggeshall, R. E., and K. Chung. 1984. The determination of an empirical correction factor to deal with the problem of nucleolar splitting in neuronal counts. J. Neurosci. Methods 10:149-155.
13. Couderc, T., F. Chretien, C. Schilte, O. Disson, M. Brigitte, F. Guivel-Benhassine, Y. Touret, G. Barau, N. Cayet, I. Schuffenecker, P. Despres, F. Arenzana-Seisdedos, A. Michault, M. L. Albert, and M. Lecuit. 2008. A mouse model for chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS. Pathog. 4:e29.
14. Ding, Y., L. He, Q. Zhang, Z. Huang, X. Che, J. Hou, H. Wang, H. Shen, L. Qiu, Z. Li, J. Geng, J. Cai, H. Han, X. Li, W. Kang, D. Weng, P. Liang, and S. Jiang. 2004. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J. Pathol. 203:622-630.
15. Dong, Y., and E. N. Benveniste. 2001. Immune function of astrocytes. Glia 36:180-190.
16. Drosten, C., S. Gunther, W. Preiser, S. van der Werf, H. R. Brodt, S. Becker, H. Rabenau, M. Panning, L. Kolesnikova, R. A. Fouchier, A. Berger, A. M. Burguiere, J. Cinatl, M. Eickmann, N. Escriou, K. Grywna, S. Kramme, J. C. Manuguerra, S. Muller, V. Rickerts, M. Sturmer, S. Vieth, H. D. Klenk, A. D. Osterhaus, H. Schmitz, and H. W. Doerr. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348:1967-1976.
17. Gadient, R. A., and U. H. Otten. 1997. Interleukin-6 (IL-6) - a molecule with both beneficial and destructive potentials. Prog. Neurobiol. 52:379-390.
18. Ghoshal, A., S. Das, S. Ghosh, M. K. Mishra, V. Sharma, P. Koli, E. Sen, and A. Basu. 2007. Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis. Glia 55:483-496.
19. Glass, W. G., K. Subbarao, B. Murphy, and P. M. Murphy. 2004. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J. Immunol. 173:4030-4039.
20. Gu, J., E. Gong, B. Zhang, J. Zheng, Z. Gao, Y. Zhong, W. Zou, J. Zhan, S. Wang, Z. Xie, H. Zhuang, B. Wu, H. Zhong, H. Shao, W. Fang, D. Gao, F. Pei, X. Li, Z. He, D. Xu, X. Shi, V. M. Anderson, and A. S. Leong. 2005. Multiple organ infection and the pathogenesis of SARS. J. Exp. Med. 202:415-424.
21. Harmer, D., M. Gilbert, R. Borman, and K. L. Clark. 2002. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. 532:107-110.
22. Jacomy, H., and P. J. Talbot. 2001. Susceptibility of murine CNS to OC43 infection. Adv. Exp. Med. Biol. 494:101-107.
23. Kim, T. S., and S. Perlman. 2005. Virus-specific antibody, in the absence of T cells, mediates demyelination in mice infected with a neurotropic coronavirus. Am. J. Pathol. 166:801-809.
24. Ksiazek, T. G., D. Erdman, C. S. Goldsmith, S. R. Zaki, T. Peret, S. Emery, S. Tong, C. Urbani, J. A. Comer, W. Lim, P. E. Rollin, S. F. Dowell, A. E. Ling, C. D. Humphrey, W. J. Shieh, J. Guarner, C. D. Paddock, P. Rota, B. Fields, J. DeRisi, J. Y. Yang, N. Cox, J. M. Hughes, J. W. LeDuc, W. J. Bellini, and L. J. Anderson. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348:1953-1966.
25. Lau, K. K., W. C. Yu, C. M. Chu, S. T. Lau, B. Sheng, and K. Y. Yuen. 2004. Possible central nervous system infection by SARS coronavirus. Emerg. Infect. Dis. 10:342-344.
26. Lavi, E., P. S. Fishman, M. K. Highkin, and S. R. Weiss. 1988. Limbic encephalitis after inhalation of a murine coronavirus. Lab. Investig. 58:31-36.
27. Law, H. K., C. Y. Cheung, H. Y. Ng, S. F. Sia, Y. O. Chan, W. Luk, J. M. Nicholls, J. S. Peiris, and Y. L. Lau. 2005. Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells. Blood 106:2366-2374.
28. Lee, D. T., Y. K. Wing, H. C. Leung, J. J. Sung, Y. K. Ng, G. C. Yiu, R. Y. Chen, and H. F. Chiu. 2004. Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study. Clin. Infect. Dis. 39:1247-1249.
29. Li, W., M. J. Moore, N. Vasilieva, J. Sui, S. K. Wong, M. A. Berne, M. Somasundaran, J. L. Sullivan, K. Luzuriaga, T. C. Greenough, H. Choe, and M. Farzan. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450-454.
30. Lokensgard, J. R., M. C. Cheeran, S. Hu, G. Gekker, and P. K. Peterson. 2002. Glial cell responses to herpesvirus infections: role in defense and immunopathogenesis. J. Infect. Dis. 186(Suppl. 2):S171-S179.
31. Matthews, A. E., S. R. Weiss, and Y. Paterson. 2002. Murine hepatitis virus - a model for virus-induced CNS demyelination. J. Neurovirol. 8:76-85.
32. McCray, P. B., Jr., L. Pewe, C. Wohlford-Lenane, M. Hickey, L. Manzel, L. Shi, J. Netland, H. P. Jia, C. Halabi, C. D. Sigmund, D. K. Meyerholz, P. Kirby, D. C. Look, and S. Perlman. 2007. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J. Virol. 81:813-821.
33. Ng, M. L., S. H. Tan, E. E. See, E. E. Ooi, and A. E. Ling. 2003. Proliferative growth of SARS coronavirus in Vero E6 cells. J. Gen. Virol. 84:3291-3303.
34. Pavelko, K. D., C. L. Howe, K. M. Drescher, J. D. Gamez, A. J. Johnson, T. Wei, R. M. Ransohoff, and M. Rodriguez. 2003. Interleukin-6 protects anterior horn neurons from lethal virus-induced injury. J. Neurosci. 23:481-492.
35. 34a. Paxinos, G., and K. B. J. Franklin. 2001. The mouse brain in stereotaxic coordinates, 2nd ed. Academic Press, New York, NY.
36. Peiris, J. S., S. T. Lai, L. L. Poon, Y. Guan, L. Y. Yam, W. Lim, J. Nicholls, W. K. Yee, W. W. Yan, M. T. Cheung, V. C. Cheng, K. H. Chan, D. N. Tsang, R. W. Yung, T. K. Ng, and K. Y. Yuen. 2003. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361:1319-1325.
37. Perlman, S., and A. A. Dandekar. 2005. Immunopathogenesis of coronavirus infections: implications for SARS. Nat. Rev. Immunol. 5:917-927.
38. Plakhov, I. V., E. E. Arlund, C. Aoki, and C. S. Reiss. 1995. The earliest events in vesicular stomatitis virus infection of the murine olfactory neuroepithelium and entry of the central nervous system. Virology 209:257-262.
39. Roberts, A., D. Deming, C. D. Paddock, A. Cheng, B. Yount, L. Vogel, B. D. Herman, T. Sheahan, M. Heise, G. L. Genrich, S. R. Zaki, R. Baric, and K. Subbarao. 2007. A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice. PLoS Pathog. 3:e5.
40. Roberts, A., J. Wood, K. Subbarao, M. Ferguson, D. Wood, and T. Cherian. 2006. Animal models and antibody assays for evaluating candidate SARS vaccines: summary of a technical meeting 25-26 August 2005, London, UK. Vaccine 24:7056-7065.
41. Rota, P. A., M. S. Oberste, S. S. Monroe, W. A. Nix, R. Campagnoli, J. P. Icenogle, S. Penaranda, B. Bankamp, K. Maher, M. H. Chen, S. Tong, A. Tamin, L. Lowe, M. Frace, J. L. DeRisi, Q. Chen, D. Wang, D. D. Erdman, T. C. Peret, C. Burns, T. G. Ksiazek, P. E. Rollin, A. Sanchez, S. Liffick, B. Holloway, J. Limor, K. McCaustland, M. Olsen-Rasmussen, R. Fouchier, S. Gunther, A. D. Osterhaus, C. Drosten, M. A. Pallansch, L. J. Anderson, and W. J. Bellini. 2003. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300:1394-1399.
42. Schluter, D., M. Deckert, H. Hof, and K. Frei. 2001. Toxoplasma gondii infection of neurons induces neuronal cytokine and chemokine production, but gamma interferon- and tumor necrosis factor-stimulated neurons fail to inhibit the invasion and growth of T. gondii. Infect. Immun. 69:7889-7893.
43. Sharafeldin, A., R. Eltayeb, M. Pashenkov, and M. Bakhiet. 2000. Chemokines are produced in the brain early during the course of experimental African trypanosomiasis. J. Neuroimmunol. 103:165-170.
44. Spiegel, M., K. Schneider, F. Weber, M. Weidmann, and F. T. Hufert. 2006. Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells. J. Gen. Virol. 87:1953-1960.
45. Stertz, S., M. Reichelt, M. Spiegel, T. Kuri, L. Martinez-Sobrido, A. Garcia-Sastre, F. Weber, and G. Kochs. 2007. The intracellular sites of early replication and budding of SARS-coronavirus. Virology 361:304-315.
46. Stockman, L. J., R. Bellamy, and P. Garner. 2006. SARS: systematic review of treatment effects. PLoS Med. 3:e343.
47. Subbarao, K., and A. Roberts. 2006. Is there an ideal animal model for SARS? Trends Microbiol. 14:299-303.
48. Sun, N., D. Grzybicki, R. F. Castro, S. Murphy, and S. Perlman. 1995. Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus. Virology 213:482-493.
49. Suzuki, S., K. Tanaka, E. Nagata, D. Ito, T. Dembo, and Y. Fukuuchi. 1999. Cerebral neurons express interleukin-6 after transient forebrain ischemia in gerbils. Neurosci. Lett. 262:117-120.
50. Tseng, C. T., C. Huang, P. Newman, N. Wang, K. Narayanan, D. M. Watts, S. Makino, M. M. Packard, S. R. Zaki, T. S. Chan, and C. J. Peters. 2007. Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human angiotensin-converting enzyme 2 virus receptor. J. Virol 81:1162-1173.
51. Tseng, C. T., L. A. Perrone, H. Zhu, S. Makino, and C. J. Peters. 2005. Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection. J. Immunol. 174:7977-7985.
52. Van Wagoner, N. J., J. W. Oh, P. Repovic, and E. N. Benveniste. 1999. Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor. J. Neurosci. 19:5236-5244.
53. Wehn, S. M., E. R. Heinz, P. C. Burger, and O. B. Boyko. 1989. Dilated Virchow-Robin spaces in cryptococcal meningitis associated with AIDS: CT and MR findings. J. Comput. Assist. Tomogr. 13:756-762.
54. Xu, J., S. Zhong, J. Liu, L. Li, Y. Li, X. Wu, Z. Li, P. Deng, J. Zhang, N. Zhong, Y. Ding, and Y. Jiang. 2005. Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis. Clin. Infect. Dis. 41:1089-1096.
55. Yamashita, M., M. Yamate, G. M. Li, and K. Ikuta. 2005. Susceptibility of human and rat neural cell lines to infection by SARS-coronavirus. Biochem. Biophys. Res. Commun. 334:79-85.
56. Zhang, X., K. Wu, D. Wang, X. Yue, D. Song, Y. Zhu, and J. Wu. 2007. Nucleocapsid protein of SARS-CoV activates interleukin-6 expression through cellular transcription factor NF-κB. Virology 365:324-335.
57. Ziegler, T., S. Matikainen, E. Ronkko, P. Osterlund, M. Sillanpaa, J. Siren, R. Fagerlund, M. Immonen, K. Melen, and I. Julkunen. 2005. Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells. J. Virol. 79:13800-13805.